Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02268400

Ligand	Ligand name	Chain	PDB	Tanimoto
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.77
DM3	6-DEOXYDAUNOMYCIN	A	1D14	0.71
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.78
CHR	NEOCARZINOSTATIN-CHROMOPHORE	A	1O5P	0.72
CHR	NEOCARZINOSTATIN-CHROMOPHORE	A,B	1NCO	0.72
429	2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY-3-HYDROXY-PHENYL)-PROPIONYLAMINO]-BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER	A	1QXK	0.73
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.72
C39	N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)-5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)-8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE	C,O	2V12	0.71
GGO	(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE	B	2OQI	0.73
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AL9	0.73
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AGL	0.73
GNT	(-)-GALANTHAMINE	A	1DX6	0.71
GNT	(-)-GALANTHAMINE	A	1QTI	0.71
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.71
GNT	(-)-GALANTHAMINE	A,B	1W76	0.71
GNT	(-)-GALANTHAMINE	A	1W6R	0.71
BNR	BIS-DAUNORUBICIN	B	1AMD	0.72
DM1	DAUNOMYCIN	A	152D	0.7
DM1	DAUNOMYCIN	A,B,C,D	1O0K	0.7
DM1	DAUNOMYCIN	A	1JO2	0.7
DM1	DAUNOMYCIN	A,B	308D	0.7
DM1	DAUNOMYCIN	A	1D33	0.7
DM1	DAUNOMYCIN	A	110D	0.7
DM1	DAUNOMYCIN	A	1D11	0.7
DM1	DAUNOMYCIN	A	427D	0.7
DM1	DAUNOMYCIN	A	2D34	0.7
DM1	DAUNOMYCIN	A	3F8F	0.7
DM1	DAUNOMYCIN	A	1D10	0.7
DM1	DAUNOMYCIN	A	1DA0	0.7
CX6	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	A,B,C,D,E,F	2AL4	0.78
C01	(2S)-(4-ISOPROPYLPHENYL)[(2-METHYL-3-OXO-5,7-DIPROPYL-2,3-DIHYDRO-1,2-BENZISOXAZOL-6-YL)OXY]ACETATE	A	1ZEO	0.75
DM6	4'-EPIDOXORUBICIN	A	1D15	0.7
DM6	4'-EPIDOXORUBICIN	A	1D54	0.7
DM6	4'-EPIDOXORUBICIN	A	1D58	0.7
DM6	4'-EPIDOXORUBICIN	A	1QDA	0.7
DM2	DOXORUBICIN	A	2DR6	0.7
DM2	DOXORUBICIN	A	1P20	0.7
DM2	DOXORUBICIN	A	1I1E	0.7
DM2	DOXORUBICIN	A	151D	0.7
DM2	DOXORUBICIN	A	1D12	0.7
DM2	DOXORUBICIN	A	1DA9	0.7
BA1	BALANOL	A	1BX6	0.72
C40	N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)-5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE	A	2V13	0.7
HMT	(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine	0,1,2,3,9,A,B,C,F,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G6E	0.72
EH5	N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]-[2-(HEXAHYDRO-BENZO[1,3]DIOXOL-5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)-4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE	A	1LF3	0.75